| __timestamp | Exelixis, Inc. | Halozyme Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23068000 | 52602000 |
| Thursday, January 1, 2015 | 33277000 | 105812000 |
| Friday, January 1, 2016 | 184902000 | 113485000 |
| Sunday, January 1, 2017 | 437411000 | 285461000 |
| Monday, January 1, 2018 | 827478000 | 141726000 |
| Tuesday, January 1, 2019 | 934678000 | 150446000 |
| Wednesday, January 1, 2020 | 951266000 | 224227000 |
| Friday, January 1, 2021 | 1382097000 | 361897000 |
| Saturday, January 1, 2022 | 1553153000 | 520812000 |
| Sunday, January 1, 2023 | 1757661000 | 636892000 |
| Monday, January 1, 2024 | 2168701000 | 855907000 |
Unlocking the unknown
In the dynamic world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Exelixis, Inc. and Halozyme Therapeutics, Inc. have shown remarkable growth in their gross profits. Starting in 2014, Exelixis reported a modest gross profit, but by 2023, it had skyrocketed by over 7,500%, reaching its peak. This impressive growth reflects Exelixis's strategic advancements and market positioning.
Conversely, Halozyme Therapeutics, while also experiencing growth, saw a more moderate increase of approximately 1,100% over the same period. This steady rise highlights Halozyme's consistent performance and resilience in the competitive biotech sector.
The data underscores the contrasting growth trajectories of these two companies, offering valuable insights for investors and industry analysts. As the biotech landscape continues to evolve, monitoring such financial trends becomes crucial for making informed decisions.
Who Generates Higher Gross Profit? Johnson & Johnson or Exelixis, Inc.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated and Exelixis, Inc.: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Exelixis, Inc.: A Gross Profit Performance Breakdown
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Gross Profit Comparison: BioMarin Pharmaceutical Inc. and Exelixis, Inc. Trends
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Exelixis, Inc. and Lantheus Holdings, Inc.
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Trends